retatrutide dehydration Promises Big Weight Loss, but Safety Remains a Question Retatrutide GLP-3 | Advanced Triple-Agonist

Clinical trials demonstrate reductions in waist circumference and visceral adipose tissue alongside overall weight loss of 820% depending on the specific medication

Weight changes typically begin within 2-4 weeks

10.1111/j.1365-2982.2011.01750.x Neurogastroenterol

The first is we started the conversation today with your introductory remarks, and you had mentioned some of the FDA indications

Were already at the point where its become a class indicator to possess these drugs

A regulatory filing (NDA/BLA with the FDA, MAA with the EMA) would follow compilation of the complete clinical data package after Phase 3 completion